Skip Navigation



Bioinformatics Advance Access published online on March 20, 2008
Bioinformatics, doi:10.1093/bioinformatics/btn103
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
24/9/1191    most recent
btn103v1
Right arrow Comments: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jayawardhana, B.
Right arrow Articles by Rattray, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jayawardhana, B.
Right arrow Articles by Rattray, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2008). Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Bayesian Inference of the Sites of Perturbations in Metabolic Pathways via Markov Chain Monte Carlo

Bayu Jayawardhana 1,2,*, Douglas B. Kell 1,2 and Magnus Rattray 3

1Manchester Interdisciplinary Biocentre, The University of Manchester, 131 Princess St., Manchester M1 7DN, UK.
2School of Chemistry, The University of Manchester, Manchester M13 9PL, UK.
3School of Computer Science, The University of Manchester, Manchester M13 9PL, UK.

*To whom correspondence should be addressed. Dr. Bayu Jayawardhana, E-mail: bayujw{at}ieee.org


  Abstract

Motivation: Genetic modifications or pharmaceutical interventions can influence multiple sites in metabolic pathways, and often these are 'distant' from the primary effect. In this regard, the ability to identify target and off-target effects of a specific compound or gene therapy is both a major challenge and critical in drug discovery.

Results: We applied Markov Chain Monte Carlo (MCMC) for parameter estimation and perturbation identification in the kinetic modeling of metabolic pathways. Variability in the steady-state measurements in cells taken from a population can be caused by differences in initial conditions within the population, by variation of parameters among individuals and by possible measurement noise. MCMC-based parameter estimation is proposed as a method to help in inferring parameter distributions, taking into account uncertainties in the initial conditions and in the measurement data. The inferred parameter distributions are then used to predict changes in the network via a simple classification method. The proposed technique is applied to analyze changes in the pathways of pyruvate metabolism of mutants of Lactococcus lactis, based on previously published experimental data.

Availability: MATLAB code used in the simulations is available from ftp://anonymous@dbkweb.mib.man.ac.uk/pub/Bioinformatics_BJ.zip

Contact: bayujw{at}ieee.org, dbk{at}manchester.ac.uk, magnus.rattray{at}manchester.ac.uk

Supplementary information: Supplementary material is available from the journal website.

Associate Editor: Prof. Thomas Lengauer

Received on January 29, 2008; revised on February 22, 2008; accepted on March 15, 2008

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.